Literature DB >> 25319389

Marine sponge Cribrochalina vasculum compounds activate intrinsic apoptotic signaling and inhibit growth factor signaling cascades in non-small cell lung carcinoma.

Ana Zovko1, Kristina Viktorsson2, Petra Hååg1, Dimitry Kovalerchick3, Katarina Färnegårdh4, Andrea Alimonti5, Micha Ilan6, Shmuel Carmeli3, Rolf Lewensohn1.   

Abstract

Marine-derived compounds have been explored and considered as possible antitumor agents. In this study, we analyzed extracts of the sponge Cribrochalina vasculum for their ability to inhibit tumor cell proliferation. Screening identified two acetylenic compounds of similar structure that showed strong tumor-specific toxicity in non-small cell lung carcinoma (NSCLC) cells and small-cell lung carcinoma cells, and less prominent toxicity in ovarian carcinoma, while having no effect on normal cells. These acetylenic compounds were found to cause a time-dependent increase in activation of apoptotic signaling involving cleavage of caspase-9, caspase-3, and PARP, as well as apoptotic cell morphology in NSCLC cells, but not in normal fibroblasts. Further analysis demonstrated that these compounds caused conformational change in Bak and Bax, and resulted in loss of mitochondrial potential and cytochrome c release in NSCLC cells. Moreover, a decreased phosphorylation of the growth factor signaling kinases Akt, mTOR, and ERK was evident and an increased phosphorylation of JNK was observed. Thus, these acetylenic compounds hold potential as novel therapeutic agents that should be further explored for NSCLC and other tumor malignancies. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25319389     DOI: 10.1158/1535-7163.MCT-14-0329

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  7 in total

Review 1.  Advances in exploring the therapeutic potential of marine natural products.

Authors:  Xiao Liang; Danmeng Luo; Hendrik Luesch
Journal:  Pharmacol Res       Date:  2019-07-25       Impact factor: 7.658

2.  Selective Toxicity of Non Polar Bioactive Compounds of Persian Gulf Sea Squirt Phallusia Nigra on Skin Mitochondria Isolated from Rat Model of Melanoma

Authors:  Yalda Arast; Nina Seyed Razi; Enayatollah Seydi; Parvaneh Naserzadeh; Melika Nazemi; Jalal Pourahmad
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

Review 3.  Anti-lung Cancer Marine Compounds: A Review.

Authors:  Mohammad Reza Miri; Afshin Zare; Jamileh Saberzadeh; Neda Baghban; Iraj Nabipour; Amin Tamadon
Journal:  Ther Innov Regul Sci       Date:  2022-01-13       Impact factor: 1.778

4.  SDR enzymes oxidize specific lipidic alkynylcarbinols into cytotoxic protein-reactive species.

Authors:  Pascal Demange; Etienne Joly; Julien Marcoux; Yves Génisson; Remi Chauvin; Patrick R A Zanon; Dymytrii Listunov; Pauline Rullière; Cécile Barthes; Céline Noirot; Jean-Baptiste Izquierdo; Alexandrine Rozié; Karen Pradines; Romain Hee; Maria Vieira de Brito; Marlène Marcellin; Remy-Felix Serre; Olivier Bouchez; Odile Burlet-Schiltz; Maria Conceição Ferreira Oliveira; Stéphanie Ballereau; Vania Bernardes-Génisson; Valérie Maraval; Patrick Calsou; Stephan M Hacker; Sébastien Britton
Journal:  Elife       Date:  2022-05-10       Impact factor: 8.713

5.  Compounds from the marine sponge Cribrochalina vasculum offer a way to target IGF-1R mediated signaling in tumor cells.

Authors:  Ana Zovko; Metka Novak; Petra Hååg; Dimitry Kovalerchick; Teresa Holmlund; Katarina Färnegårdh; Micha Ilan; Shmuel Carmeli; Rolf Lewensohn; Kristina Viktorsson
Journal:  Oncotarget       Date:  2016-08-02

Review 6.  Molecular Targets of Active Anticancer Compounds Derived from Marine Sources.

Authors:  Xiaoping Song; Ying Xiong; Xin Qi; Wei Tang; Jiajia Dai; Qianqun Gu; Jing Li
Journal:  Mar Drugs       Date:  2018-05-22       Impact factor: 5.118

7.  Cytotoxic Alkylynols of the Sponge Cribrochalina vasculum: Structure, Synthetic Analogs and SAR Studies.

Authors:  Dimitry Kovalerchik; Ana Zovko; Petra Hååg; Adam Sierakowiak; Kristina Viktorsson; Rolf Lewensohn; Micha Ilan; Shmuel Carmeli
Journal:  Mar Drugs       Date:  2022-04-13       Impact factor: 6.085

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.